Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial

INTRODUCTION: Prolonged use of antivirals to prevent the development of cytomegalovirus (CMV) disease in lung transplant patients has been shown to have significant side effects, for which alternatives are being sought to reduce their use. The monitoring of cell immunity against CMV could be an alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Paez-Vega, Aurora, Cantisan, Sara, Vaquero, José Manuel, Vidal, Elisa, Luque-Pineda, Antonio, Lobo-Acosta, María Ángeles, Pérez, Ana Belén, Alonso-Moralejo, Rodrigo, Iturbe, David, Monforte, Victor, Otero-Gonzalez, Isabel, Pastor, Amparo, Ussetti, Piedad, Torre-Cisneros, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701703/
https://www.ncbi.nlm.nih.gov/pubmed/31420397
http://dx.doi.org/10.1136/bmjopen-2019-030648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701703/
https://www.ncbi.nlm.nih.gov/pubmed/31420397
http://dx.doi.org/10.1136/bmjopen-2019-030648

Ejemplares similares